CL2016001801A1 - Proceso para la reconstitución de una forma sólida de una composición farmacéutica. - Google Patents

Proceso para la reconstitución de una forma sólida de una composición farmacéutica.

Info

Publication number
CL2016001801A1
CL2016001801A1 CL2016001801A CL2016001801A CL2016001801A1 CL 2016001801 A1 CL2016001801 A1 CL 2016001801A1 CL 2016001801 A CL2016001801 A CL 2016001801A CL 2016001801 A CL2016001801 A CL 2016001801A CL 2016001801 A1 CL2016001801 A1 CL 2016001801A1
Authority
CL
Chile
Prior art keywords
pressure
pharmaceutical composition
reconstitution
solid form
time
Prior art date
Application number
CL2016001801A
Other languages
English (en)
Inventor
Xavier Payet-Burin
Original Assignee
Ucb Biopharma Sprl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50033446&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2016001801(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ucb Biopharma Sprl filed Critical Ucb Biopharma Sprl
Publication of CL2016001801A1 publication Critical patent/CL2016001801A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F29/00—Mixers with rotating receptacles
    • B01F29/60—Mixers with rotating receptacles rotating about a horizontal or inclined axis, e.g. drum mixers
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F2101/00—Mixing characterised by the nature of the mixed materials or by the application field
    • B01F2101/22—Mixing of ingredients for pharmaceutical or medical compositions
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F2101/00—Mixing characterised by the nature of the mixed materials or by the application field
    • B01F2101/2202—Mixing compositions or mixers in the medical or veterinary field

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

Proceso para la reconstitución de una forma sólida de una composición farmacéutica que comprende los siguientes pasos sucesivos: (i) proporcionar la forma sólida de la composición farmacéutica en un recipiente sellado, siendo la presión dentro del recipiente una presión inicial (pi) comprendida entre 0,5 Pa y 1,2 x 105 Pa; (ii) a un primer punto del tiempo (t0) introducir el disolvente en el recipiente sellado y mantener la presión resultante (pr) dentro del recipiente durante un tiempo controlado (t1); y (iii) a un segundo punto del tiempo (t2) incrementar la presión dentro del recipiente a una presión controlada (p2) mayor que la presión resultante (pr) hasta completar la reconstitución.
CL2016001801A 2014-01-20 2016-07-14 Proceso para la reconstitución de una forma sólida de una composición farmacéutica. CL2016001801A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP14305070 2014-01-20

Publications (1)

Publication Number Publication Date
CL2016001801A1 true CL2016001801A1 (es) 2017-05-05

Family

ID=50033446

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2016001801A CL2016001801A1 (es) 2014-01-20 2016-07-14 Proceso para la reconstitución de una forma sólida de una composición farmacéutica.

Country Status (15)

Country Link
US (1) US10376467B2 (es)
EP (1) EP3096743B1 (es)
JP (1) JP6397933B2 (es)
KR (1) KR102325240B1 (es)
CN (1) CN106163501B (es)
AU (1) AU2015207464B2 (es)
BR (1) BR112016016690A2 (es)
CA (1) CA2936721C (es)
CL (1) CL2016001801A1 (es)
ES (1) ES2916825T3 (es)
IL (1) IL246619A0 (es)
MX (1) MX2016009347A (es)
RU (1) RU2016133973A (es)
SG (1) SG11201605862WA (es)
WO (1) WO2015107214A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2960646A1 (en) * 2014-06-27 2015-12-30 F. Hoffmann-La Roche AG Method for determining whether reconstitution of a solution in a container is completed
EP3558366A1 (en) * 2016-12-22 2019-10-30 H. Hoffnabb-La Roche Ag Methods and formulations for reducing reconstitution time of lyophilized polypeptides
AU2020340299B2 (en) * 2019-08-29 2023-10-26 Eli Lilly And Company Crystalline forms of a CD73 inhibitor
IL303673A (en) 2020-12-23 2023-08-01 Tolmar International Ltd Systems and methods for mixing injector valve assemblies

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4741900A (en) 1982-11-16 1988-05-03 Cytogen Corporation Antibody-metal ion complexes
US4543101A (en) 1984-03-28 1985-09-24 Adria Laboratories, Inc. Valve device to aid in reconstituting injectable powders
GB8720833D0 (en) 1987-09-04 1987-10-14 Celltech Ltd Recombinant dna product
US6307026B1 (en) 1992-12-10 2001-10-23 Celltech Limited Humanized antibodies directed against A33 antigen
FR2716640B1 (fr) 1994-02-28 1996-05-03 Procedes Machines Speciales Dispositif de centrage et de blocage d'une pièce en vue de son rodage à l'aide d'un rodoir à expansion.
KR100546726B1 (ko) * 1996-06-04 2006-10-24 소시에떼 더 콘세이유 더 레세르세 에 다플리까띠옹 시엔띠피끄, 에스.아.에스. 주사제를제조하는방법및장치
GB9625640D0 (en) 1996-12-10 1997-01-29 Celltech Therapeutics Ltd Biological products
US6358236B1 (en) * 1998-08-06 2002-03-19 Baxter International Inc. Device for reconstituting medicaments for injection
DE10211227A1 (de) * 2002-03-13 2003-10-02 Aventis Behring Gmbh Verfahren zur Rekonstitution von Iyophilisierten Proteinen
GB0303337D0 (en) 2003-02-13 2003-03-19 Celltech R&D Ltd Biological products
DK2995331T3 (da) * 2004-09-10 2019-01-02 Becton Dickinson Co Rekonstitutonsinfusionsindretning og fremgangsmåde til rekostituering af et medikament
US7523946B2 (en) * 2005-06-20 2009-04-28 Xerox Corporation Expandable chuck
US9309316B2 (en) * 2005-12-20 2016-04-12 Bristol-Myers Squibb Company Stable subcutaneous protein formulations and uses thereof
CA2709781C (en) * 2007-12-28 2017-03-14 Baxter International Inc. Counter-pressure filtration of proteins
US20110155620A1 (en) * 2009-12-30 2011-06-30 Baxter International Inc. Rapid reconstitution for lyophilized-pharmaceutical suspensions
CA2861722C (en) 2011-12-29 2020-06-30 Omrix Biopharmaceuticals Ltd. Method and device for fast dissolution of solid protein composition
US9731076B2 (en) * 2012-06-29 2017-08-15 Ethicon, Inc. Multi-compartment pre-filled mixing syringes with bypass

Also Published As

Publication number Publication date
JP2017505339A (ja) 2017-02-16
KR20160135176A (ko) 2016-11-25
AU2015207464B2 (en) 2019-10-03
CA2936721C (en) 2021-12-14
WO2015107214A1 (en) 2015-07-23
ES2916825T3 (es) 2022-07-06
US20160331682A1 (en) 2016-11-17
RU2016133973A (ru) 2018-03-05
EP3096743A1 (en) 2016-11-30
MX2016009347A (es) 2017-02-02
CN106163501A (zh) 2016-11-23
IL246619A0 (en) 2016-08-31
US10376467B2 (en) 2019-08-13
KR102325240B1 (ko) 2021-11-11
JP6397933B2 (ja) 2018-09-26
AU2015207464A1 (en) 2016-07-28
EP3096743B1 (en) 2022-02-16
SG11201605862WA (en) 2016-08-30
CN106163501B (zh) 2019-05-31
BR112016016690A2 (pt) 2018-03-20
RU2016133973A3 (es) 2018-07-11
CA2936721A1 (en) 2015-07-23

Similar Documents

Publication Publication Date Title
CL2017000092A1 (es) Contenedor flexible con accesorios y proceso para producirlo
MX2023010685A (es) Recipientes para el almacenamiento anaerobico de sangre.
MX2015005238A (es) Unidad de empaque de un producto farmacuetico, medico o cosmetico y un metodo de esterilizacion de un producto farmaceutico, medico o cosmetico que se puede colocar en la unidad de empaque.
CL2015002857A1 (es) Contenedor recargable a presión con una válvula de escape.
GB2557030A (en) Method and apparatus for identifying fluids behind casing
MX2020003430A (es) Derivados de 1-bencil-2-imino-4-fenil-5-oxoimidazolidina como inhibidores de proteasa de virus de inmunodeficiencia humana.
AR101221A1 (es) Recipiente flexible con montaje y proceso para su producción
CL2016001801A1 (es) Proceso para la reconstitución de una forma sólida de una composición farmacéutica.
EP3306174A4 (en) High pressure gas container
SA517381153B1 (ar) سدادة مُحسنة
CR20180228A (es) Terapia adjunta con 25-hidroxi vitamina d y articulos de la misma
UY36055A (es) Dispersión sólida amorfa que comprende taxano, comprimido que la contiene y método para prepararla
AR103256A1 (es) Artículo generador de aerosol que comprende un tubo transparente
AR101511A1 (es) Sistema y método para crear un pliegue en una porción de material expandible
AR100050A1 (es) Proceso para acidificación usando formulaciones ácidas retardadas
EP3365536A4 (en) HIGH-PRESSURE LIQUID AIR POWER AND STORAGE
PE20151852A1 (es) Un aparato para molienda
CL2016001964A1 (es) Sistema para preparar un producto elaborado
CL2017001834A1 (es) Contenedor de palé que tiene un forro interior
EP3239232A4 (en) Saponified ethylene-vinyl ester copolymer resin composition, resin tube or resin liner for composite container for high pressure gas, and high pressure gas hose or composite container
CR20150136A (es) Balón intragástrico
MY183596A (en) Resin container
AR099285A1 (es) Polieteraminas secundarias como inhibidores de hidratos del gas natural, en bajas dosis
CL2017001258A1 (es) Generación de inmunidad
MX2017005084A (es) Barrera de manchas de laminado y tubo.